THE BEHAVIORAL TOXICITY OF ANTIDEPRESSANTS - EFFECTS ON COGNITION ANDSEXUAL FUNCTION

Authors
Citation
I. Hindmarch, THE BEHAVIORAL TOXICITY OF ANTIDEPRESSANTS - EFFECTS ON COGNITION ANDSEXUAL FUNCTION, International clinical psychopharmacology, 13, 1998, pp. 5-8
Citations number
13
Categorie Soggetti
Pharmacology & Pharmacy",Psychiatry
ISSN journal
02681315
Volume
13
Year of publication
1998
Supplement
6
Pages
5 - 8
Database
ISI
SICI code
0268-1315(1998)13:<5:TBTOA->2.0.ZU;2-1
Abstract
The cognitive system is structured from sets of schema, patterns of ne ural activity that allow the assimilation or accommodation of new expe riences and so, by a process of consolidation, the gradual development of knowledge and understanding,As well as schema for purely cognitive processes, there are similar structures that enable individuals to de al with sexual behaviour and affectual relationships (e,g. hedonia, se lf-esteem, personal preferences and body image), In depression, there is a well established disruption of cognitive function that results in anhedonia and a loss of pleasure, including that from sexual activiti es. Many antidepressants also have a direct pharmacological action on the central nervous system and disrupt cognitive function, so increasi ng anhedonia and impairing sexual function, Drug actions on cognitive structures, which in turn increase anhedonia and reduce sexual libido, are over and above any direct pharmacological effects on the more ove rt behavioural activities associated with sex, including orgasm, erect ile function, potency and ejaculation. The tricyclic antidepressants, for example, destroy the cognitive structures that are vital to mainta in normal libido as well as disturbing overt sexual behaviours, Some s elective serotonin reuptake inhibitors (SSRIs; paroxetine and sertrali ne) are associated with behavioural activation that is also responsibl e for an impairment of sexual function. However, there are clear diffe rences between the SSRIs, and fluvoxamine (relative to the other SSRIs ) has little effect on objective measures of cognition or on cerebral and behavioural components of sexual function. Int Clin Psychopharmaco l 13 (suppl 6)S5-S8.